Kazia Therapeutics
KZIA
35 hedge funds and large institutions have $50.7M invested in Kazia Therapeutics in 2026 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 5 closing their positions.
1,384% more call options, than puts
Call options by funds: $6.4M | Put options by funds: $431K
289% more capital invested
Capital invested by funds: $13M → $50.7M (+$37.7M)
240% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 5
150% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 4
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
52% more funds holding
Funds holding: 23 → 35 (+12)
16.5% more ownership
Funds ownership: 15.35% → 31.85% (+17%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Boxer Capital Management
San Diego,
California
|
+$6.82M |
| 2 |
IC
Ikarian Capital
Dallas,
Texas
|
+$4.83M |
| 3 |
DIG
Dauntless Investment Group
Etna,
New Hampshire
|
+$3.34M |
| 4 |
FLPIM
F.L. Putnam Investment Management
Lynnfield,
Massachusetts
|
+$3.32M |
| 5 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
+$1.35M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Balyasny Asset Management
Chicago,
Illinois
|
-$1.44M |
| 2 |
VCIM
Velan Capital Investment Management
Alpharetta,
Georgia
|
-$1.01M |
| 3 |
SFA
Sequoia Financial Advisors
Akron,
Ohio
|
-$487K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$255K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$106K |
KZIA Hedge Fund Activity: Q2 2026 in Review
35 of the 8,340 institutional investors tracked by Wall St. Rank reported a position in Kazia Therapeutics (KZIA) for Q2 2026, worth a combined $50.7M — up 289% from $13M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new KZIA positions and 5 closed out — a net gain of 12 holders — while 10 added to existing stakes and 4 trimmed.
The largest buyer was Boxer Capital Management, opening a new position worth an estimated $6.82M. The largest seller was Balyasny Asset Management, exiting entirely with an estimated $1.44M sold.
- 35 institutional investors held Kazia Therapeutics (KZIA) as of Q2 2026, up from 23 in Q1 2026.
- Funds reported $50.7M of Kazia Therapeutics stock for Q2 2026, up 289% quarter-over-quarter.
- 17 funds opened new Kazia Therapeutics positions in Q2 2026 and 5 closed out, a net change of +12 holders.
- The largest Kazia Therapeutics buyer in Q2 2026 was Boxer Capital Management, an estimated $6.82M added.
- The largest Kazia Therapeutics seller in Q2 2026 was Balyasny Asset Management, an estimated $1.44M sold.
Based on aggregated 13F filings for Q2 2026.